3 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Withdrawn 3 |
Follow Insomnia: new trials by email Literature Review of Insomnia trials Research Report on Insomnia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients Best Practice, Electronic Health Record Review, Interview - Advanced Malignant Solid Neoplasm, Delirium | Phase 4 | Withdrawn | Mayo Clinic | 2025-02-26 | 2025-05-01 | |
| Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia Suvorexant (Belsomra), Placebo - Bipolar Disorder, Insomnia | Phase 4 | Withdrawn | Massachusetts General Hospital | 2019-02-26 | 2021-02-21 | |
| Ramelteon for Complex Insomnia in Veterans With PTSD Ramelteon, Usual Care - Insomnia | Phase 4 | Withdrawn | State University of New York at Buffalo | 2018-01-01 | 2021-04-09 |
Sleep Initiation and Maintenance Disorders (3) · Bipolar Disorder (1) · Delirium (1) · Sleep Apnea Syndromes (1) · Stress Disorders, Post-Traumatic (1)
Dyssomnias (3) · Mental Disorders (3) · Nervous System Diseases (3) · Sleep Disorders, Intrinsic (3) · Sleep Wake Disorders (3) · Apnea (1) · Bipolar and Related Disorders (1) · Confusion (1) · Mood Disorders (1) · Neurobehavioral Manifestations (1) · Neurocognitive Disorders (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1)
suvorexant (2) · Interviews as Topic (1) · Practice Guidelines as Topic (1) · Standard of Care (1) · ramelteon (1)
Massachusetts General Hospital (1) · Mayo Clinic (1) · State University of New York at Buffalo (1)
United States (2)
Ali El Solh, MD (1) · Gustavo Kinrys, MD (1) · Regina M. Mackey, MD (1)